156 related articles for article (PubMed ID: 38447110)
1. Investigating the Impact of Tumor Biology and Social Determinants on Time to Diagnosis and Stage at Presentation of Wilms Tumor.
Collins A; Molina Kuna E; Anderson-Mellies A; Cost C; Green AL
J Pediatr Hematol Oncol; 2024 Apr; 46(3):147-153. PubMed ID: 38447110
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor: a 10 year retrospective study.
Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
[TBL] [Abstract][Full Text] [Related]
3. Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group.
Fernandez CV; Li N; Mullen EA; Grundy PE; Perman EJ; Shamberger RC; Ehrlich PF; Dome JS
J Pediatr Hematol Oncol; 2011 Oct; 33(7):521-3. PubMed ID: 21941145
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
5. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Ortiz MV; Ahmed S; Burns M; Henssen AG; Hollmann TJ; MacArthur I; Gunasekera S; Gaewsky L; Bradwin G; Ryan J; Letai A; He Y; Naranjo A; Chi YY; LaQuaglia M; Heaton T; Cifani P; Dome JS; Gadd S; Perlman E; Mullen E; Steen H; Kentsis A
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391345
[TBL] [Abstract][Full Text] [Related]
6. Wilms tumor: 15 years of experience at a children's hospital in Córdoba, Argentina.
Seminara C; Planells MC; Pogonza RE; Morales M;
Arch Argent Pediatr; 2019 Aug; 117(4):263-270. PubMed ID: 31339273
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG).
Neville H; Ritchey ML; Shamberger RC; Haase G; Perlman S; Yoshioka T
J Pediatr Surg; 2002 Aug; 37(8):1134-7. PubMed ID: 12149688
[TBL] [Abstract][Full Text] [Related]
8. Botryoid Wilms Tumor: A Rare Diagnosis With an Atypical Presentation.
Probst PJ; Assadi A; Gleason J
Urology; 2019 Apr; 126():192-194. PubMed ID: 30735745
[TBL] [Abstract][Full Text] [Related]
9. [A case of adult Wilms' tumor].
Wahafu W; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):334-8. PubMed ID: 18560467
[TBL] [Abstract][Full Text] [Related]
10. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
[TBL] [Abstract][Full Text] [Related]
11. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
12. New approaches to risk stratification for Wilms tumor.
Nelson MV; van den Heuvel-Eibrink MM; Graf N; Dome JS
Curr Opin Pediatr; 2021 Feb; 33(1):40-48. PubMed ID: 33394739
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor 1991. Clinical evaluation and treatment.
Exelby PR
Urol Clin North Am; 1991 Aug; 18(3):589-97. PubMed ID: 1652172
[TBL] [Abstract][Full Text] [Related]
14. Atypical presentation of Wilms' tumor: evaluation and early diagnosis.
Yarboro TL
J Natl Med Assoc; 1998 Jan; 90(1):51-3. PubMed ID: 9473930
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
Dix DB; Fernandez CV; Chi YY; Mullen EA; Geller JI; Gratias EJ; Khanna G; Kalapurakal JA; Perlman EJ; Seibel NL; Ehrlich PF; Malogolowkin M; Anderson J; Gastier-Foster J; Shamberger RC; Kim Y; Grundy PE; Dome JS;
J Clin Oncol; 2019 Oct; 37(30):2769-2777. PubMed ID: 31449468
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor in horseshoe kidney: presentation due to ureteropelvic junction obstruction.
Nirgiotis JG; Black CT; Sherman JO
J Surg Oncol; 1991 Nov; 48(3):210-2. PubMed ID: 1658496
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation of rhabdoid tumors of the kidney.
Amar AM; Tomlinson G; Green DM; Breslow NE; de Alarcon PA
J Pediatr Hematol Oncol; 2001 Feb; 23(2):105-8. PubMed ID: 11216700
[TBL] [Abstract][Full Text] [Related]
18. Wilms Tumor: Challenges and Newcomers in Prognosis.
Parsons LN
Surg Pathol Clin; 2020 Dec; 13(4):683-693. PubMed ID: 33183727
[TBL] [Abstract][Full Text] [Related]
19. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
[TBL] [Abstract][Full Text] [Related]
20. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.
Breslow NE; Collins AJ; Ritchey ML; Grigoriev YA; Peterson SM; Green DM
J Urol; 2005 Nov; 174(5):1972-5. PubMed ID: 16217371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
